In this patient, CD4 and CD8 T-cell receptor repertoires were different in the CSF and tumor, indicating that ICI enhanced two pre-existing immune responses, one directed against the tumor, and another one directed against the CNS (48). This evidence concerns the gene CD8A and neoplasm.